Beijing Biostar Pharmaceuticals Co. Ltd. primarily focuses on developing innovative therapies for tumors. The company is dedicated to creating novel anti-cancer drugs, each secured by independent intellectual property rights. A prominent product in its portfolio is the Utidelone injection, a next-generation microtubule inhibitor produced through a unique microbial fermentation process. This enterprise was co-founded by Li Tang and Rong Guo Qiu on July 11, 2002, and operates from its headquarters in Beijing, China.
常見問題
Beijing Biostar Pharmaceuticals. 今天的股價是多少?▼
2563.HK 目前價格為 HK$3.50 HKD,過去 24 小時下跌了 -5.41%。在圖表上更密切關注 Beijing Biostar Pharmaceuticals. 股票的表現。
Beijing Biostar Pharmaceuticals. 的股票代號是什麼?▼
根據交易所不同,股票代號可能會有所差異。例如,在 Hong Kong Exchange 交易所,Beijing Biostar Pharmaceuticals. 的股票以代號 2563.HK 進行交易。
Beijing Biostar Pharmaceuticals. 的股價在上漲嗎?▼
2563.HK 股票較上週下跌 -7.89%,本月下跌 -27.84%,但在過去一年中,Beijing Biostar Pharmaceuticals. 上漲了 +10.06%。
Beijing Biostar Pharmaceuticals. 的市值是多少?▼
今天 Beijing Biostar Pharmaceuticals. 的市值為 1.28B
Beijing Biostar Pharmaceuticals. 去年的營收是多少?▼
Beijing Biostar Pharmaceuticals. 去年的營收為 30.42MHKD。
Beijing Biostar Pharmaceuticals. 去年的淨利是多少?▼
2563.HK 去年的淨收益為 -145.33MHKD。
Beijing Biostar Pharmaceuticals. 有多少名員工?▼
截至 2026年11月3日,公司共有 134 名員工。
Beijing Biostar Pharmaceuticals. 位於哪個產業?▼
Beijing Biostar Pharmaceuticals.從事於Health & Wellness產業。
Beijing Biostar Pharmaceuticals. 何時完成拆股?▼
Beijing Biostar Pharmaceuticals. 最近沒有進行任何拆股。
Beijing Biostar Pharmaceuticals. 的總部在哪裡?▼
Beijing Biostar Pharmaceuticals. 的總部位於 中國 的 Beijing。